ESMO Media Releases

Clinical activity with a second drug inhibiting KRAS^G12C confirms its role as a therapeutic target in patients with advanced non-small-cell lung cancer (NSCLC) harbouring this mutation, according to results from a study with the KRAS^G12C inhibitor adagrasib reported at the European Lung Cancer Virtual Congress 2021.

The increasing complexity of treatments for lung cancer and language differences can make it difficult for patients to communicate with their medical teams

The European Lung Cancer Congress 2021, the annual event devoted to advance the quality of lung cancer treatment, will be held as a virtual meeting.

The ESMO Targeted Anticancer Therapies Congress 2021, designed for basic scientists, physicians and translational researchers belonging to academic settings, industry and regulatory agencies will be held as a virtual meeting.

Researchers Predict Over 1.4 Million Deaths From Top 10 Cancers in 2021 in the EU and UK. Accompanying Editorial Warns of Adverse Effect of COVID-19 on Death Rates.

A study of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall.

The global coronavirus pandemic has disrupted cancer research, prevention and treatment to an extent never seen before.

The ESMO Immuno-Oncology Congress 2020, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as a virtual meeting.

The ESMO Asia Congress 2020, the leading scientific platform in the Asia-Pacific region, will be held as a virtual meeting. 

The Molecular Analysis for Precision oncology (MAP) Congress is designed to answer the critical question about how to integrate the wealth of information coming from the analysis of tumour samples into daily practice.